Anti-Proliferative Effects of Selenium in HT-29 Colon Cancer Cells via Inhibition of Akt |
Park, Song-Yi
(Department of Biological Sciences, College of Life Science and Nano Technology, Hannam University)
Kim, In-Seop (Department of Biological Sciences, College of Life Science and Nano Technology, Hannam University) Lee, Se-Hee (Department of Biological Sciences, College of Life Science and Nano Technology, Hannam University) Lee, Sol-Hwa (Department of Biological Sciences, College of Life Science and Nano Technology, Hannam University) Jung, Da-Woon (Department of Biological Sciences, College of Life Science and Nano Technology, Hannam University) Park, Ock-Jin (Department of Food and Nutrition, College of Life Science and Nano Technology, Hannam University) Kim, Young-Min (Department of Biological Sciences, College of Life Science and Nano Technology, Hannam University) |
1 | Lee, Y. K., S. Y. Park, Y. M. Kim, D. C. Kim, W. S. Lee, Y. J. Surh, and O. J. Park. 2010. Suppression of mTOR via Akt-dependent and -independent mechanisms in selenium- treated colon cancer cells: involvement of AMPKalpha1. Carcinogenesis 31, 1092-1099. DOI ScienceOn |
2 | Li, X. Y., X. R. Zhan, X. M. Liu, and X. C. Wang. 2011. CREB is a regulatory target for the protein kinase Akt/PKB in the differentiation of pancreatic ductal cells into islet -cells mediated by hepatocyte growth factor. Biochem. Biophys. Res. Commun. 404, 711-716. DOI ScienceOn |
3 | Li, Y. B., J. Y. Han, W. Jiang, and J. Wang. 2011. Selenium inhibits high glucose-induced cyclooxygenase-2 and P-selectin expression in vascular endothelial cells. Mol. Biol. Rep. 38, 2301-2306. DOI ScienceOn |
4 | Osaki, M., M. Oshimura, and H. Ito 2004. PI3K/Akt pathway: its functions and alterations in human cancer. Apoptosis 9, 667-676. DOI |
5 | Rotruck, J. T., A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. 1973. Hoekstra. Selenium: biochemical role as a component of glutathione peroxidase. Science 179, 588-90. DOI ScienceOn |
6 | Rotruck, J. T., W. G. Hoekstra, H. E. Ganther, and A. L. Pope. 1972. Prevention of oxidative damage to rat erythrocytes by dietary selenium. J. Nutr. 120, 689. |
7 | Rudolf, E., V. Kralova, and M. Cervinka. 2008. Selenium and colon cancer--from chemoprevention to new treatment modality. Anticancer Agents Med. Chem. 8. 598-602. DOI |
8 | Bellacosa, A., C. C. Kumar, C. A. Di, and J. R. Testa. 2005. Activation of Akt kinases in cancer implications for therapeutic targeting. Adv. Cancer Res. 94, 29-86. DOI |
9 | Carnero, A. 2010. The PKB/AKT pathway in cancer. Curr. Pharm. Des. 16, 34-44. DOI ScienceOn |
10 | Chao, X., J. Zao, G. Xiao-Yi, M. Li-Jun, and S. Tao. 2010. Blocking of PI3K/AKT induces apoptosis by its effect on activity in gastric carcinoma cell line SGC7901. Biomed. Pharmacother. 64. 600-604. DOI ScienceOn |
11 | Clark, L. C., G. F. Jr. Combs, B. W. Turnbull, E. H. Slate, D. K. Chalker, J. Chow, L. S. Davis, R. A. Glover, G. F. Graham, E. G. Gross, A. Krongrad, J. L. Jr. Lesher, H. K. Park, B. B. Jr. Sanders, C. L. Smith, and J. R. Taylor. 1996. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional prevention of cancer trial. JAMA 276, 1957-1963. DOI ScienceOn |
12 | Glynn, S. A., R. L. Prueitt, L. A. Ridnour, B. J. Boersma, T. M. Dorsey, D. A. Wink, J. E. Goodman, H. G. Yfantis, D. H. Lee, and S. Ambs. 2010. COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer 10, 626. DOI |
13 | Sinha, R., S. C. Kiley, J. X. Lu, H. J. Thompson, R. Moraes, S. Jaken, and D. Medina. 1999. Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. Cancer Lett. 146, 135-145. DOI ScienceOn |
14 | Tang, C. H., R. S. Yang, T. H. Huang, D. Y. Lu, W. J. Chuang, T. F. Huang, and W. M. Fu. 2006. Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mol. Pharmacol. 69, 2047-2057. DOI ScienceOn |
15 | El-Bayoumy, K. 2001. The protective role of selenium on genetic damage and on cancer. Mutat. Res. 475, 123-139. DOI |
16 | Gopalakrishna, R., Z. H. Chen, and U. Gundimeda. 1997. Seleno-compounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: its role in inhibition of tumor promotion. Arch. Biochem. Biophys. 348, 37-48. DOI ScienceOn |
17 | Han, Y. D., Y. K. Hong, J. G. Kang, Y. J. Choi, and C. H. Park. 2010. Relation of the expression of cyclooxygenase-2 in colorectal adenomas and adenocarcinomas to angiogenesis and prognosis. J. Korean Soc. Coloproctol. 26, 339-346. DOI |
18 | Kada, F., M. Saji, and M. D. Ringel. 2004. Akt: a potential target for thyroid cancer therapy. Curr. Drug Targets Immune Endocr. Metabol. Disord. 4, 181-185. DOI ScienceOn |
19 | Korkaya, H., A. Paulson, E. Charafe-Jauffret, C. Ginestier, M. Brown, J. Dutcher, S. G. Clouthier, and M. S. Wicha. 2009. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol. 7, e1000121. DOI |
20 | Yamauchi, T., M. Watanabe, T. Kubota, H. Hasegawa, Y. Ishii, T. Endo, Y. Kabeshima, K. Yorozuya, K. Yamamoto M. Mukai, and M. Kitajima. 2002. Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis. Colon Rectum. 45, 98-103. DOI ScienceOn |
21 | Lee, Y. K., S. Y. Park, Y. M. Kim, and O. J. Park. 2009. Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann. N. Y. Acad. Sci. 1171, 489-494. DOI ScienceOn |
22 | Lee, K. M., M. K. Hwang, D. E. Lee, K. W. Lee, and H. J. Lee. 2010. Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J. Agric. Food Chem. 58, 5815-5820. DOI ScienceOn |
23 | Lee, S. H., S. Y. Park, I. S. Kim, O. J. Park, and Y. M. Kim 2010. The effect of combind treatment of selenium and curcumin on Akt and mTOR regulation in Hep3B hepato- carcinoma cells. Cancer Prev. Res. 15. 285-290. |